Binding of HIV-1 to its receptor induces tyrosine phosphorylation of several CD4-associated proteins, including the phosphatidylinositol 3-kinase

Virology

Volumn 228, Issue 2, 1997, Pages 171-179

  Briand, Guylaine ^a   Barbeau, Benoît ^a   Tremblay, Michel ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; PHOSPHATIDYLINOSITOL 3 KINASE; TYROSINE; VIRUS GLYCOPROTEIN;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; VIRUS CELL INTERACTION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0031575530     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1996.8399     Document Type: Article

References (75)

1. Adachi A., Gendelman H. E., Koenig S., Folks T., Willey R., Rabson A., Martin M. A. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman transfected cells with an infectious molecular clone. J. Virol. 59:1986;284-291.
2. lck. Proc. Natl. Acad. Sci. USA. 89:1992;3343-3346.
3. Ansotegui I. J. S., Chow C., Jeddi-Tehrani M., Meloche S., Pawson A., Sékaly R.-P., Mak T. W., Wigzell H. Characterization of a monoclonal antibody directed against the phosphotyrosine kinase p56lck, in human T cells. Scand. J. Immunol. 33:1991;375-380.
4. Arthos J., Deen K. C., Chaikin M., Fornwald J. A., Sathe G., Sattentau Q. J., Clapham P. R., Weiss R. A., McDougal S. J., Pietropaolo C., Axel R., Truneh A., Maddon P. J., Sweet R. W. Identification of the residues in human CD4 critical for the binding of HIV. Cell. 57:1989;469-481.
5. Baldari C. T., Pelici G., Madalena Di Somma M., Milia E., Giuli S., Pelici P. G., Telford J. L. Inhibition of CD4/p56lck signaling by a dominant negative mutant of the Shc adaptor protein. Oncogene. 10:1995;1141-1147.
6. Bank I., Chess L. Perturbation of the T4 molecule transmits a negative signal to T cells. J. Exp. Med. 162:1985;1294-1303.
7. Benkirane M., Hirn M., Carrière D., Devaux C. Functional epitope analysis of the human CD4 molecule: Antibodies that inhibit human immunodeficiency virus type 1 gene expression bind to the immunoglobulin CDR3-like region of CD4. J. Virol. 69:1995a;6898-6903.
8. Benkirane M., Jeang K.-T., Devaux C. The cytoplasmic domain of CD4 plays a critical role during the early stages of HIV infection in T-cells. EMBO J. 13:1994;5559-5569.
9. Benkirane M., Schmid-Antomarchi H., Littman D. R., Hirn M., Rossi B., Devaux C. The cytoplasmic tail of CD4 is required for inhibition of human immunodeficiency virus type 1 replication by antibodies that bind to the immunoglobulin CDR3-like region in domain 1 of CD4. J. Virol. 69:1995b;6904-6910.
10. Bérubé P., Barbeau B., Cantin R., Sékaly R.-P., Tremblay M. Repression of human immunodeficiency virus type 1 LTR-driven gene expression by the binding of the virus to its primary cellular receptor, the CD4 molecule. J. Virol. 70:1996;4009-4016.
11. Burgess K. E., Yamamoto M., Prasad K. V. S., Rudd C. E. CD5 acts as a tyrosine kinase substrate within a receptor complex comprising T-cell receptor ζ chain/CD3 and protein tyrosine kinase p56lck and p59fyn. Proc. Natl. Acad. Sci. USA. 89:1992;9311-9315.
12. Chan A. C., Irving B. A., Fraser J. D., Weiss A. The ζ chain is associated with a tyrosine kinase and upon T cell antigen receptor stimulation associates with ZAP-70, a 70 kDa tyrosine phosphoprotein. Proc. Natl. Acad. Sci. USA. 89:1991;9166-9170.
13. Chirmurle N., Goonewardena H., Pahwa S., Pasieka R., Kalyanaraman V. S., Pahwa S. HIV-1 envelope glycoproteins induce activation of activated protein-1 in CD4+ T cells. J. Biol. Chem. 270:1995;19364-19369.
14. Couture C., Baier G., Oetken C., Williams S., Telford D., Marie-Cardine A., Baier-Bitterlich G., Fisher S., Burn P., Altman A., Mustelin T. Activation of p56lck by p72syk through physical association and N-terminal tyrosine phosphorylation. Mol. Cell. Biol. 14:1994;5249-5258.
15. Cruikshank W. W., Center D. M., Pyle S. W., Kornfeld H. Biologic activities of HIV-1 envelope glycoprotein: The effects of crosslinking. Biomed. Pharmacother. 44:1990;5-11.
16. Dalgleish A. G., Beverly P. C. L., Clapham P. R., Crawford D. H., Greaves M. F., Weiss R. A. The CD4(T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature. 312:1984;763-767.
17. Doyle C., Strominger J. Interaction between CD4 and class II MHC molecules mediates cell adhesion. Nature. 330:1987;256-259.
18. lckinteracts via its src homology 2 domain with the ZAP-70 kinase. J. Exp. Med. 179:1994;1163-1172.
19. Eichmann K., Jonsson J., Falk I., Emmrich F. Effective activation of resting mouse T lymphocyte by crosslinking submitogenic concentrations of the T cell antigen receptor with either Lyt-2 or L3T4. Eur. J. Immunol. 17:1987;643-650.
20. Emmrich F., Kantz L., Eichmann K. Cross-linking of the T cell receptor complex with the subset-specific differentiation antigen stimulates interleukin 2 receptor expression in human CD4 and CD8 T cells. Eur. J. Immunol. 17:1987;529-534.
21. Ettehadieh E., Sanghera J. S., Pelech S. L., Hess-Bienz D., Watts J., Shastri N., Abersold R. Tyrosyl phosphorylation and activation of MAP kinases by p56lck. Science. 239:1992;617-622.
22. Fantl W. J., Escobedo J. A., Martin G. A., Turck C. W., del Rosario M., McCormic F., Williams L. T. Distinct phosphotyrosines on a growth factor receptor bind to specific molecules that mediate different signaling pathways. Cell. 69:1992;413-423.
23. Foley G. E., Lazarus H., Farber S., Uzman B. G., Boone B. A., McCarthy R. E. Continuous culture of human lymphoblasts from peripheral blood of a child with acute leukemia. Cancer. 18:1965;522-529.
24. Gelderblom H. R., Reupke H., Pauli G. Loss of envelope antigens of HTLV-III/LAV, a factor in AIDS pathogenesis? Lancet. II:1985;1016-1017.
25. Goldman F., Jensen W. A., Johnson G. L., Heasly L., Cambier J. C. gp120 ligation of CD4 induces activation and TCR desensitization independent of TCR tyrosine phosphorylation. J. Immunol. 153:1994;2905-2917.
26. Gulbins E., Coggeshall K. M., Baier G., Katzav S., Burn P., Altman A. Tyrosine kinase-stimulated guanine nucleotide exchange activity of vav in T cell activation. Science. 260:1993;822-825.
27. Gupta S., Weiss A., Kumar G., Wang S., Nel A. The T-cell antigen receptor utilizes Lck, Raf-1, and MEK-1 for activating mitogen-activated protein kinase: Evidence for the existence of a second protein kinase C-dependent pathway in an Lck-negative Jurkat cell mutant. J. Biol. Chem. 269:1994;17349-17357.
28. Haffar O. K., Moran P. A., Smithgall M. D., Diegel M. L., Sridhar P., Ledbetter J. A., Zarling J. M., Hu S.-L. Inhibition of virus production in peripheral blood mononuclear cells from human immunodeficiency virus (HIV) type 1-seropositive donors by treatment with recombinant HIV-like particles. J. Virol. 66:1992;4279-4287.
29. Hara K., Yonezawa K., Sakaue H., Ando A., Kotani K., Kitamura T., Kitamura Y., Ueda H., Stephens L., Jackson T. R., Hawkins P. T., Dhand R., Clark A. E., Holman G. D., Waterfield M. D., Kasuga M. 1-Phosphatidylinositol 3-kinase activity is required for insulin-stimulated glucose transport but not for RAS activation in CHO cells. Proc. Natl. Acad. Sci. USA. 91:1994;7415-7419.
30. Hivroz C., Mazerolles F., Soula M., Fagard R., Gratton S., Meloche S., Sékaly R. P., Fischer A. Human immunodeficiency virus gp120 and derived peptides activate protein tyrosine kinase p56lck in human CD4 T lymphocytes. Eur. J. Immunol. 23:1993;600-607.
31. Horak I. D., Popovic M., Horak E. M., Lucas P. J., Gress R. E., June C. H., Bolen J. B. No T-cell tyrosine protein kinase signalling or calcium mobilization after CD4 association with HIV-1 or HIV-1 gp120. Nature. 348:1990;557-560.
32. Iwashima M., Irving B. A., van Oers N. S. C., Chan A. C., Weiss A. Sequential interactions of the TCR with two distinct cytoplasmic tyrosine kinases. Science. 263:1994;1136-1138.
33. Julius M., Newell K., Maroun C., Haughn L. Functional consequences of CD4-TCR/CD3 interactions. Semin. Immunol. 3:1991;161-170.
34. Juszczak R. J., Turchin H., Truneh A., Culp J., Kassis S. Effect of human immunodeficiency virus gp120 glycoprotein on the association of the protein tyrosine kinase p56lck with CD4 in human T lymphocytes. J. Biol. Chem. 266:1991;11176-11183.
35. Kaplan D. R., Whitman M., Schaffhausen B., Pallas D. C., White M., Cantley L. C., Roberts T. M. Common elements in growth factor stimulation and oncogenic transformation: 85 kd phosphoprotein and phosphatidylinositol kinase activity. Cell. 50:1987;1021-1029.
36. Kikukawa R., Koyanagi Y., Harada S., Kobayashi N., Hatanaka M., Yamamoto N. Differential susceptibility to the acquired immunodeficiency syndrome retrovirus in cloned cells of human leukemic T-cell line Molt-4. J. Virol. 57:1986;1159-1162.
37. Klatzmann D., Champagne E., Chamaret S., Gruest J., Guetard D., Hercend T., Gluckman J. C., Montagnier L. T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature. 312:1984;767-768.
38. Koretsky G. A., Picus J., Schultz T., Weiss A. The tyrosine phosphatase CD45 is required for T cell antigen receptor and CD2-mediated activation of a protein tyrosine kinase and interleukin 2 production. Proc. Natl. Acad. Sci. USA. 88:1991;2307-2041.
39. Kornfeld H., Cruikshank W. W., Pyle S. W., Berman J. S., Center D. M. Lymphocyte activation by HIV-1 envelope glycoprotein. Nature. 335:1988;445-448.
40. Luo K. X., Sefton B. M. Cross-linking of T-cell surface molecules CD4 and CD8 stimulates phosphorylation of the lck tyrosine kinase at the autophosphorylation site. Mol. Cell. Biol. 10:1990;5305-5313.
41. Maddon P. J., Littman D. R., Godfrey M., Maddon D. E., Chess L., Axel R. The isolation and nucleotide sequence of a cDNA encoding the T cell surface protein T4: A new member of the immunoglobulin gene family. Cell. 42:1985;93-104.
42. +. AIDS Res. Hum. Retroviruses. 5:1989;253-255.
43. McCallus D. E., Ugen K. E., Sato A. I., Williams W. V., Weiner D. B. Construction of a recombinant bacterial human CD4 expression system producing a bioactive CD4 molecule. Viral Immunol. 5:1992;163-172.
44. McKeating J. A., McKnight A., Moore J. P. Differential loss of envelope glycoprotein gp120 from virions of human immunodeficiency virus type 1 isolates: Effects on infectivity and neutralization. J. Virol. 65:1991;852-860.
45. +. J. Virol. 66:1992;4784-4793.
46. Mustelin T., Coggeshall K. M., Altman A. Rapid activation of the T-cell tyrosine protein kinase pp56lck by the CD45 phosphotyrosine phosphatase. Proc. Natl. Acad. Sci. USA. 86:1989;6302-6306.
47. Nakanishi S., Kakita S., Takahashi I., Kawahara K., Tsukuda E., Sano T., Yamada K., Yoshida M., Kase H., Matsuda Y., Hashimoto Y., Nonomura Y. Wortmannin, a microbial product inhibitor of myosin light chain kinase. J. Biol. Chem. 267:1992;2157-2163.
48. Okada T., Kawano T., Sakakibara T., Hazeki O., Ui M. Essential role of phosphatidylinositol 3-kinase in insulin-induced glucose transport and antilipolysis in rat adipocytes. J. Biol. Chem. 269:1994;3568-3573.
49. Olszowy M. W., Leuchtmann P. L., Veillette A., Shaw A. S. Comparison of p56(lck) and p59(fyn) protein expression in thymocyte subsets, peripheral T cells, NK cells, and lymphoid cell lines. J. Immunol. 155:1995;4236-4240.
50. 2+. AIDS Res. Hum. Retroviruses. 7:1991;587-593.
51. Popik W., Pitha P. M. Binding of human immunodeficiency virus type 1 to CD4 induces association of Lck and Raf-1 and activates Raf-1 by a Ras-independent pathway. Mol. Cell. Biol. 16:1996;6532-6541.
52. lckcomplex in T cells. Mol. Cell. Biol. 12:1992;5260-5267.
53. Prasad K. V. S., Kapeller R., Janssen O., Repke H., Duke-Cohan J. S., Cantley L. C., Rudd C. E. Phosphatidylinositol (PI) 3-kinase and PI 4-kinase binding to the CD4-p56lck complex: The p56lck SH3 domain binds to PI 3-kinase but not PI 4-kinase. Mol. Cell. Biol. 13:1993;7708-7717.
54. Reedquist K. A., Fukazawa T., Druker B., Panchamoorthy G., Shoelson S. E., Band H. Rapid T-cell receptor-mediated tyrosine phosphorylation of p120, an fyn/lck src homology 3 domain-binding protein. Proc. Natl. Acad. Sci. USA. 91:1994;4135-4139.
55. Resh M. D. Myristylation and palmitylation of src family members: The fats of the matter. Cell. 76:1994;411-413.
56. Ruderman N. B., Kapeller R., White M. F., Cantley L. C. Activation of phosphatidylinositol 3-kinase by insulin. Proc. Natl. Acad. Sci. USA. 87:1990;1411-1415.
57. Schmid-Antomarchi H., Benkirane M., Breittmayer V., Husson H., Ticchioni M., Devaux C., Rossi B. HIV induces activation of phosphatidylinositol 4-kinase and mitogen-activated protein kinase by interacting with T cell CD4 surface molecules. Eur. J. Immunol. 26:1996;717-720.
58. Shaw A. S., Amrein K. E., Hammond D. F., Stern D. F., Sefton B. M., Rose J. K. The lck tyrosine protein kinase interacts with the cytoplasmic tail of CD4 glycoprotein through its unique amino-terminal domain. Cell. 59:1989;627-636.
59. Shenoy-Scaria A. M., Timson Gauen L. K., Kwong J., Shaw A. S., Lublin D. M. Palmitylation of an amino-terminal cysteine motif of protein tyrosine kinases p56lck and p59fyn mediates interaction with glycosyl-phosphatidylinositol-anchored proteins. Mol. Cell. Biol. 13:1993;6385-6392.
60. Smith S. D., Shatsky, Cohen M. P. S., Warnke R., Link M. P., Glader B. E. Monoclonal antibody and enzymatic profiles of human malignant T lymphoid cells and derived cell lines. Cancer Res. 44:1984;5657-5660.
61. Soltoff S. P., Rabin S. L., Cantley L. C., Kaplan D. R. Nerve growth factor promotes the activation of phosphatidylinositol 3-kinase and its association with the trk tyrosine kinase. J. Biol. Chem. 267:1992;17472-17477.
62. Soula M., Fagard R., Fischer S. Interaction of human immunodeficiency virus glycoprotein 160 with CD4 in Jurkat cells increase p56lck. Int. Immunol. 4:1992;295-299.
63. Stefannová I., Horejsí V., Ansotegui I. J., Knapp W., Stockinger H. GPI-anchored cell-surface molecules complexed to protein tyrosine kinases. Science. 254:1991;1016-1019.
64. Tite J. P., Sloan A., Janeway C. A. Jr. The role of L3T4 in T cell activation: L3T4 may be both as an Ia binding protein and a receptor that transduces a negative signal. J. Mol. Cell. Immunol. 2:1986;179-187.
65. Tremblay M., Meloche S., Gratton S., Wainberg M. A., Sékaly R. P. Association of p56lck with the cytoplasmic domain of CD4 modulates HIV-1 expression. EMBO J. 13:1994;774-783.
66. Turner J. M., Brodsky M. H., Irving B. A., Levin S. D., Perlmutter R. M., Littman D. R. Interaction of the unique N-terminal region of tyrosine kinase p56lck with cytoplasmic domains of CD4 and CD8 is mediated by cysteine motifs. Cell. 60:1990;755-765.
67. Veillette A., Abraham N., Caron L., Davidson D. The lymphocyte-specific tyrosine protein kinase p56lck. Semin. Immunol. 3:1991;143-152.
68. Veillette A., Bolen J. B., Bookman M. A. Alterations in tyrosine protein phosphorylation induced by antibody-mediated cross-linking of the CD4 receptor of T lymphocytes. Mol. Cell. Biol. 9:1989c;4441-4446.
69. Veillette A., Bookman M. A., Horak E. M., Bolen J. B. The CD4 and CD8 T-cell surface antigens are physically associated with the internal membrane tyrosine kinase p56lck. Cell. 55:1988;301-308.
70. Veillette A., Bookman M. A., Horak E. M., Samelson L. E., Bolen J. B. Signal transduction through the CD4 receptor involves the activation of the internal membrane tyrosine-protein kinase p56lck. Nature. 338:1989a;257-259.
71. Veillette A., Horak I. D., Bolen J. B. Post-translational alterations of the tyrosine kinase p56lck in response to activators of protein kinase C. Oncogene Res. 2:1988;385-401.
72. Veillette A., Zuniga-Pflucker J. C., Bolen J. B., Kruisbeek A. M. Engagement of CD4 and CD8 expressed on immature thymocytes induces activation of intracellular tyrosine phosphorylation pathways. J. Exp. Med. 170:1989b;1671-1680.
73. Vogel L. B., Fujita D. J. The SH3 domain of p56lck is involved in binding to phosphatidylinositol 3′-kinase from T lymphocytes. Mol. Cell. Biol. 13:1993;7408-7417.
74. Weber J. R., Bell G. M., Han M. Y., Pawson T., Imboden J. B. Association of the tyrosine kinase lck with phospholipase C-γ1 after stimulation of the T cell antigen receptor. J. Exp. Med. 176:1992;373-379.
75. Weiss A., Imboden J., Shoback D., Strobo J. Role of T3 surface molecules in human T-cell activation: T3-dependent activation results in an increase in cytoplasmic free calcium. Proc. Natl. Acad. Sci. USA. 81:1984;4169-4173.